Clinical Trial Update: Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating clarithromycin, lenalidomide, and dexamethasone in relapsed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• clarithromycin, lenalidomide and dexamethasone

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Multiple Myeloma in Relapse | Phase 2 | Status: UNKNOWN